FDA Inspection 1167399 — Innovative Blood Resources, A Division of New York Blood Center, Inc.

Innovative Blood Resources, A Division of New York Blood Center, Inc. — FEI 3004494970

The FDA completed an inspection of Innovative Blood Resources, A Division of New York Blood Center, Inc. on March 22, 2022 in Eden Prairie, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 22, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Eden Prairie, MN (United States)